Zydus Lifesciences Limited
532321
ISIN INE010B01027 / Valor 29835501
Zydus Lifesciences Limited
UMushroom community rating:
About company
Zydus Lifesciences Limited (formerly Cadila Healthcare, renamed 2022) is one of India's leading pharmaceutical companies, incorporated in 1995 and headquartered at Zydus Corporate Park, Khoraj, Ahmedabad. Part of the Zydus Group (Pankaj R Patel), the company researches, develops, manufactures and markets branded generics, new chemical entities, biologics and consumer wellness products across India and globally. Key brands include Lipaglyn (world's first approved NASH drug), and a wide range of biosimilars. Zydus serves the US (second-largest generics filer by ANDA count), India, Europe and emerging markets. In March 2026, Zydus and Torrent Pharmaceuticals entered a licensing pact. Listed on both BSE and NSE (ZYDUSLIFE), a Nifty 50 constituent.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
11423 M
Market cap (USD)
97,912
Daily traded volume (Shares)
/
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
